Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

University of Toronto

$85,000.00

Discovery of novel biomarkers for Downs Syndrome by proteomic analysis of amniotic fluid and amniocyte-conditioned media

EF 2010-11

Résumé
Down syndrome (DS), caused by an extra chromosome 21, affects 1 in 750 live births, and is characterized by cognitive impairment as well as congenital defects and increased risk for several diseases such as leukemia. Current non-invasive screening tests for DS have sub-optimal sensitivity and specificity, subjecting many women to follow-up invasive diagnostic methods. Proteomic analysis of samples by mass spectrometry (MS) allows identification of a large number of proteins in complex biological mixtures. We have recently published the most comprehensive list of proteins present in human amniotic fluid by using high resolution MS. In this grant application, we intend to perform quantitative analysis of proteins from human amniotic fluid and amniotic fluid cells, obtained from normal and DS pregnancies, in our efforts to discover novel screening biomarkers for DS. Our approach integrates both label-based and label-free MS methods of quantification, to perform a high-throughput comparison of the proteins from the two conditions. Candidates will be bioinformatically analyzed to delineate their biological functions in the context of DS, and will be further validated with clinical samples. The novel markers may have the potential to increase the predictive value of current screening tests and to reduce the number of unnecessary amniocenteses. In short, we aim to improve current screening tests for DS, performed in the blood of pregnant women.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
380660-2009
Name nom
Diamandis, Eleftherios
Department département
Laboratory Medicine and Pathobiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
85000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1100
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Health, education and social services
Area of application fr
Santé publique, éducation et services sociaux
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
2
Nb partie
4
Application title
Discovery of novel biomarkers for Downs Syndrome by proteomic analysis of amniotic fluid and amniocyte-conditioned media
Keyword
NSERC
Application summary
Down syndrome (DS), caused by an extra chromosome 21, affects 1 in 750 live births, and is characterized by cognitive impairment as well as congenital defects and increased risk for several diseases such as leukemia. Current non-invasive screening tests for DS have sub-optimal sensitivity and specificity, subjecting many women to follow-up invasive diagnostic methods. Proteomic analysis of samples by mass spectrometry (MS) allows identification of a large number of proteins in complex biological mixtures. We have recently published the most comprehensive list of proteins present in human amniotic fluid by using high resolution MS. In this grant application, we intend to perform quantitative analysis of proteins from human amniotic fluid and amniotic fluid cells, obtained from normal and DS pregnancies, in our efforts to discover novel screening biomarkers for DS. Our approach integrates both label-based and label-free MS methods of quantification, to perform a high-throughput comparison of the proteins from the two conditions. Candidates will be bioinformatically analyzed to delineate their biological functions in the context of DS, and will be further validated with clinical samples. The novel markers may have the potential to increase the predictive value of current screening tests and to reduce the number of unnecessary amniocenteses. In short, we aim to improve current screening tests for DS, performed in the blood of pregnant women.